Albellar, Joey I.

HRN: 06-77-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2025
CEFUROXIME 750MG (VIAL)
09/17/2025
09/23/2025
IV
675mg
Q8
T/C UTI VS URTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines